A Phase II Randomized, Observer-Blind, Multi-Center, Controlled Study of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Phase of Trial: Phase II
Latest Information Update: 12 Aug 2016
At a glance
- Drugs Streptococcal B vaccine (Primary)
- Indications Streptococcal infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Novartis
- 01 Feb 2016 Results published in the Obstetrics and Gynecology
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2013 Planned End Date changed from 1 Nov 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.